Neurologic Imaging

Should You Order MRI for Cognitive Decline with Behavioral Changes or Aphasia?

·
Should You Order MRI for Cognitive Decline with Behavioral Changes or Aphasia?

A 58-year-old high school principal is brought in by his wife. Over the past year, he has become uncharacteristically apathetic, socially withdrawn, and has made inappropriate, impulsive comments at faculty meetings. His wife also notes he struggles to find words, often using vague terms like “that thing” for common objects. His memory for recent events seems intact, but his personality has fundamentally changed. You suspect a frontotemporal dementia (FTD) spectrum disorder and need to decide on the initial imaging workup. This article details the clinical workflow for this specific scenario, guiding you to the most appropriate first study. Based on the American College of Radiology (ACR) Appropriateness Criteria, an `MRI head without IV contrast` is rated Usually Appropriate for this presentation.

Who Fits This Clinical Scenario?

This guidance applies to adult patients presenting with a subacute or chronic cognitive decline characterized by prominent behavioral or language deficits, where frontotemporal dementia is a leading clinical consideration. The key features are a significant change in personality, social conduct, or executive function, or a progressive, isolated decline in language abilities (aphasia).

Inclusion criteria for this workflow include:

  • Behavioral Changes: New-onset disinhibition, apathy, loss of empathy, compulsive behaviors, or significant changes in dietary habits.
  • Progressive Aphasia: Worsening difficulty with word-finding, grammar, sentence construction, or word comprehension, out of proportion to other cognitive deficits.

This workflow is distinct from other dementia workups. Exclude patients whose primary and most prominent initial symptom is memory loss, which is more suggestive of typical Alzheimer disease. Similarly, patients whose initial presentation is dominated by visual hallucinations or parkinsonian motor symptoms would fit the criteria for a suspected dementia with Lewy bodies workup, which follows a different imaging pathway.

What Diagnoses Are You Working Up in This Scenario?

When suspecting frontotemporal dementia, imaging serves to find supportive evidence and, crucially, to exclude mimics. The differential diagnosis is focused on disorders that affect the frontal and temporal lobes.

Frontotemporal Dementia, behavioral variant (bvFTD): This is the most common FTD syndrome and the primary diagnosis of concern. It is characterized by progressive changes in personality, behavior, and executive function. Imaging is sought to identify the classic pattern of focal atrophy and hypometabolism in the frontal and/or anterior temporal lobes, which can be symmetric or asymmetric.

Primary Progressive Aphasia (PPA): PPA refers to a group of clinical syndromes where language is the first and most significantly affected cognitive domain. It is a common presentation of underlying frontotemporal lobar degeneration. Imaging is critical for differentiating PPA subtypes—such as nonfluent/agrammatic, semantic, and logopenic variants—as each is associated with a distinct pattern of focal atrophy in the language networks of the brain.

Atypical Alzheimer Disease (AD): While classic AD presents with memory loss due to medial temporal lobe and parietal atrophy, atypical variants can mimic FTD. For example, a frontal variant of AD can present with executive dysfunction. Imaging helps differentiate the pattern of atrophy, and in some cases, advanced imaging can identify the underlying amyloid pathology characteristic of AD.

Other Neurodegenerative Conditions: Less commonly, conditions like Corticobasal Degeneration (CBD) or Progressive Supranuclear Palsy (PSP) can have overlapping clinical features with FTD. These disorders often have characteristic, though sometimes subtle, patterns of asymmetric atrophy or midbrain atrophy on MRI that can point toward the correct diagnosis.

Why Is MRI Head without IV Contrast the Recommended Study for This Presentation?

The ACR designates `MRI head without IV contrast` as Usually Appropriate for the initial evaluation of suspected FTD because it provides the best structural detail to identify the hallmark finding: focal cortical atrophy.

Magnetic Resonance Imaging (MRI) offers superior soft-tissue contrast compared to other modalities, making it highly sensitive for detecting the often subtle and asymmetric volume loss in the frontal and temporal lobes that characterizes FTD and its variants. High-resolution T1-weighted sequences are essential for this volumetric assessment. Furthermore, sequences like FLAIR (Fluid-Attenuated Inversion Recovery) are excellent for ruling out other pathologies such as stroke, inflammation, or tumors that could mimic a neurodegenerative process.

Several alternative studies are rated for this scenario, but MRI without contrast remains the primary choice for specific reasons:

  • CT head without IV contrast: While also rated Usually Appropriate, CT has lower sensitivity for early or subtle cortical atrophy. It is a reasonable first-line option if MRI is unavailable, contraindicated (e.g., incompatible pacemaker), or if the patient is claustrophobic. However, a normal CT does not exclude FTD, and MRI may still be required.
  • MRI head without and with IV contrast: This study is rated Usually not appropriate. In a typical degenerative workup, the addition of gadolinium-based contrast does not add diagnostic value. FTD is a non-enhancing process. Contrast administration should be reserved for cases where there is a specific concern for a tumor, infection, or inflammatory condition based on atypical clinical features.
  • FDG-PET/CT brain: This is also rated Usually Appropriate and is a powerful functional imaging tool. It can detect patterns of hypometabolism in the frontal and temporal lobes, sometimes even before significant atrophy is visible on MRI. However, it is often considered a second-line or problem-solving tool when the MRI is equivocal or the clinical picture is complex. It involves ionizing radiation (1-10 mSv) and is more costly and less widely available than MRI.

From a safety perspective, MRI avoids the ionizing radiation associated with CT and PET studies. The `MRI head without IV contrast` carries a radiation level of 0 mSv, making it the safest option for initial structural assessment.

What’s Next After MRI Head without IV Contrast? Downstream Workflow

The results of the initial MRI will guide your next steps in management and further diagnostics. The workflow branches based on whether the findings are positive, negative, or indeterminate for frontotemporal lobar degeneration.

If the MRI is positive for focal frontal and/or temporal atrophy: A finding of atrophy consistent with the patient’s clinical syndrome strongly supports a diagnosis of FTD or PPA. The next step is referral to a neurologist or a specialized cognitive/behavioral neurology center for comprehensive management. This may include symptomatic treatments, family counseling and support, and in some cases, genetic testing, as a subset of FTD cases are familial.

If the MRI is negative or shows only generalized atrophy: A normal structural MRI does not rule out early-stage FTD. In this situation, if clinical suspicion remains high, the next step may be to consider functional imaging. An `FDG-PET/CT brain`, which is rated Usually Appropriate, can reveal a characteristic pattern of hypometabolism even before structural changes are apparent. This can provide crucial evidence to support the diagnosis.

If the MRI is indeterminate or shows an atypical pattern: Sometimes, the pattern of atrophy may not be classic for FTD. For example, if there is more posterior-predominant atrophy, the workup may need to be redirected toward an atypical Alzheimer disease presentation. If there is suspicion for underlying amyloid pathology, an `Amyloid PET/CT brain` (May be appropriate) could be considered, though its use is highly specialized and often guided by a dementia expert.

Pitfalls to Avoid (and When to Get Help)

In the workup of suspected frontotemporal dementia, several common pitfalls can delay diagnosis or lead to misinterpretation. Be mindful of accepting a “normal for age” MRI report when the clinical suspicion for FTD is high; early atrophy can be subtle and may require an experienced neuroradiologist’s review. Another pitfall is attributing early, subtle behavioral changes solely to a psychiatric condition like depression, thereby delaying a neurodegenerative workup. Finally, avoid ordering a contrast-enhanced MRI as a default, as it is unnecessary for this indication and adds cost and potential risk without benefit.

If the clinical picture and imaging findings are discordant, or if the diagnosis remains unclear after initial imaging, escalation to a neurologist with expertise in cognitive disorders is the most appropriate next step.

Related ACR Topics and Tools

This article focuses on a single clinical scenario. For a comprehensive overview of imaging for all forms of dementia, consult the parent topic hub. For additional decision support, the following GigHz resources are available:

Frequently Asked Questions

Why is MRI without contrast preferred over CT when both are rated ‘Usually Appropriate’?

MRI without contrast is preferred because its superior soft-tissue resolution is more sensitive for detecting the subtle and focal patterns of brain atrophy that are characteristic of frontotemporal dementia (FTD). While CT can identify more advanced atrophy, it may miss early changes. MRI is the more definitive structural imaging test for this specific diagnosis.

My patient has a pacemaker and cannot get an MRI. What is the best alternative?

If MRI is contraindicated, the ACR rates ‘CT head without IV contrast’ as ‘Usually Appropriate’ and it is the best alternative for initial structural assessment. If the CT is non-diagnostic but clinical suspicion for FTD remains high, an ‘FDG-PET/CT brain’ scan, also rated ‘Usually Appropriate’, can provide valuable functional information about brain metabolism to support the diagnosis.

Should I order an Amyloid PET scan for a patient with suspected FTD?

An Amyloid PET scan is rated ‘May be appropriate’ in this scenario. It is not a first-line test for suspected FTD. Its primary role is to detect amyloid plaques, the pathology of Alzheimer disease. It may be considered by a specialist if there is a diagnostic dilemma, specifically to rule out an atypical, FTD-like presentation of Alzheimer disease.

The MRI report came back as ‘mild generalized cerebral atrophy, consistent with age.’ What should I do?

This finding is nonspecific and does not rule out an early neurodegenerative process like FTD. The key imaging feature in FTD is focal, asymmetric atrophy, not generalized volume loss. If your clinical suspicion remains high based on the patient’s behavioral or language symptoms, the next step would be to consider functional imaging with an FDG-PET/CT scan or refer to a cognitive neurology specialist for further evaluation.

Does a normal MRI rule out frontotemporal dementia?

No, a normal MRI does not definitively rule out FTD, especially in the early stages of the disease. Clinical symptoms can precede visible structural changes on MRI. If the MRI is normal but the clinical syndrome is highly suggestive of FTD, the diagnosis can still be made clinically, and functional imaging like FDG-PET may be pursued to find supportive evidence.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 29, 2026